Marshall University Launches Latest Clinical Trial Cohort for Non-Opioid Treatment of Neonatal Opioid Withdrawal
September 05, 2024
September 05, 2024
HUNTINGTON, West Virginia, Sept. 5 -- Marshall University issued the following news release:
A new clinical trial at the Marshall University Joan C. Edwards School of Medicine and Marshall Health Network aims to evaluate the safety and efficacy of oral lofexidine, a non-opioid investigational medication, in newborns who suffer from neonatal opioid withdrawal syndrome (NOWS) or neonatal abstinence syndrome (NAS) due to prenatal exposure to opioids.
This is the second co . . .
A new clinical trial at the Marshall University Joan C. Edwards School of Medicine and Marshall Health Network aims to evaluate the safety and efficacy of oral lofexidine, a non-opioid investigational medication, in newborns who suffer from neonatal opioid withdrawal syndrome (NOWS) or neonatal abstinence syndrome (NAS) due to prenatal exposure to opioids.
This is the second co . . .